• Schedule 13D/G History

BIOTECHNOLOGY VALUE FUND L P - Significant Ownership

Signature - Title
Biotechnology Value Fund L P - Mark N. Lampert, Authorized Signatory
Location
San Francisco, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by BIOTECHNOLOGY VALUE FUND L P.

Significant Ownership of BIOTECHNOLOGY VALUE FUND L P

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
XOMA XOMA Royalty Corp Common Stock, $0.0075 par value 25.3% $60.5M 2.98M BVF GP HOLDINGS LLC Jan 24, 2025
EPIX ESSA Pharma Inc. Common Shares 19.7% $15M 8.75M BVF PARTNERS L P/IL Apr 9, 2025
VSTM Verastem, Inc. Common Stock, $0.0001 par value per share 9.99% $33.9M 4.71M BVF PARTNERS L P/IL Dec 31, 2024
CDTX Cidara Therapeutics, Inc. Common Stock, par value $0.0001 per share 9.99% $25.2M 1.09M BVF PARTNERS L P/IL Dec 31, 2024
FDMT 4D Molecular Therapeutics, Inc. Common Stock, par value $0.0001 per share 9.99% $20M 4.83M BVF PARTNERS L P/IL Dec 31, 2024
AVTX Avalo Therapeutics, Inc. Common Stock, $0.001 par value per share 9.99% $7.71M 1.04M BVF PARTNERS L P/IL Dec 31, 2024
FBRX Forte Biosciences, Inc. Common Stock, $0.001 par value 9.99% $3.86M 644K BVF PARTNERS L P/IL Dec 31, 2024
VTGN Vistagen Therapeutics, Inc. Common Stock, par value $0.001 per share 9.97% $8.61M 3.08M BVF PARTNERS L P/IL Dec 31, 2024
IVA Inventiva S.A. Ordinary Shares, nominal value EUR0.01 per share 9% $25.6M 8.55M BVF PARTNERS L P/IL Dec 19, 2024
RAPT RAPT Therapeutics, Inc. Common Stock, $0.0001 par value per share 8.7% $14.7M 11.8M BVF PARTNERS L P/IL Dec 27, 2024
IKNA Ikena Oncology, Inc. Common Stock, par value $0.001 per share 8.3% $3.39M 4.01M BVF PARTNERS L P/IL Dec 31, 2024
TYRA Tyra Biosciences, Inc. Common Stock, $0.0001 par value per share 7.8% $42.4M 3.94M BVF PARTNERS L P/IL Dec 31, 2024
KURA Kura Oncology, Inc. Common Stock, par value $0.0001 per share 7.5% $45.6M 5.91M BVF PARTNERS L P/IL Jan 27, 2025
GLUE Monte Rosa Therapeutics, Inc. Common Stock, $0.0001 par value per share 7.2% $26.8M 4.39M BVF PARTNERS L P/IL Jan 24, 2025
ETNB 89bio, Inc. Common Stock, par value $0.001 per share 3.6% $31M 4.33M BVF PARTNERS L P/IL Dec 31, 2024
ENGN enGene Holdings Inc. Common Shares, no par value per share 1.8% $5M 945K BVF PARTNERS L P/IL Jan 27, 2025
THRD Third Harmonic Bio, Inc. Common Stock, par value $0.0001 per share 0% $0 0 BIOTECHNOLOGY VALUE FUND L P Apr 14, 2025

Schedules 13D/G Reported by BIOTECHNOLOGY VALUE FUND L P:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.